LINDSAY OVERKO: Open Payments
NPI 1972648111 · CONCORD, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$15,521 in 140 payments from 12 companies in 2025. Trend: 2023 $1,991 · 2024 $10,633 · 2025 $15,521
Consulting: $8,192Food & beverage: $4,871Speaker / faculty: $1,380Travel & lodging: $940Education: $138
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 37 | $6,121 |
| GENZYME CORPORATION | 20 | $2,933 |
| Regeneron Healthcare Solutions, Inc. | 10 | $2,328 |
| Arcutis Biotherapeutics, Inc. | 14 | $2,271 |
| ABBVIE INC. | 18 | $867 |
| Janssen Biotech, Inc. | 27 | $440 |
| E.R. Squibb & Sons, L.L.C. | 9 | $247 |
| UCB, Inc. | 1 | $108 |
| Amgen Inc. | 1 | $94 |
| SANOFI-AVENTIS U.S. LLC | 1 | $85 |
Products named: DUPIXENT, OPZELURA, SKYRIZI, TREMFYA, Zoryve, RINVOQ, Sotyktu, Bimzelx.
Industry payments across NH — which companies pay providers there.
